Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer

ABSTRACT: Phase II study of TAS-102 plus bevacizumab switch maintenance therapy in patients with mCRC

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2206138 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR